Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06239155
What this trial is testing

A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Ascentawits Pharmaceuticals, Ltd 51
Testing effectiveness (Phase 2)Study completedNCT00257426
What this trial is testing

Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
UNC Lineberger Comprehensive Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT03519997
What this trial is testing

Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
David Hsieh 35
Testing effectiveness (Phase 2)Looking for participantsNCT07042919
What this trial is testing

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaCirrhosisStage III Hepatocellular Carcinoma AJCC v8+1 more
Devalingam Mahalingam 59
Not applicableLooking for participantsNCT07395635
What this trial is testing

Phase II Trial of Immunonutrition in Hepatectomy

Who this might be right for
Hepatocellular CarcinomaASA I-III Patients
Tata Memorial Centre 100
Testing effectiveness (Phase 2)UnknownNCT02987699
What this trial is testing

Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT05194293
What this trial is testing

Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer

Who this might be right for
Stage IB Hepatocellular Carcinoma AJCC v8Stage II Hepatocellular Carcinoma AJCC v8Stage III Hepatocellular Carcinoma AJCC v8+1 more
Academic and Community Cancer Research United 4
Testing effectiveness (Phase 2)Looking for participantsNCT06261125
What this trial is testing

Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)

Who this might be right for
Hepatocellular Carcinoma
Mian XI 60
Testing effectiveness (Phase 2)Study completedNCT01003015
What this trial is testing

Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Bayer 36
Not applicableLooking for participantsNCT06265350
What this trial is testing

Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases

Who this might be right for
Hepatocellular CarcinomaLiver Cancer Stage IVPulmonary Metastases+3 more
Sun Yat-sen University 80
Not applicableNot Yet RecruitingNCT07115550
What this trial is testing

A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Huai'an First People's Hospital 24
Testing effectiveness (Phase 2)UnknownNCT03124498
What this trial is testing

Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA

Who this might be right for
Hepatocellular Carcinoma
Chuan An Biotechnology Co., Ltd. 55
Testing effectiveness (Phase 2)Study completedNCT04011033
What this trial is testing

Study of Adoptive Transfer of iNKT Cells Combined With TAE/TACE to Treat Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Beijing YouAn Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00280618
What this trial is testing

Oxaliplatin in Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Sanofi
Testing effectiveness (Phase 2)Study completedNCT00365391
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Looking for participantsNCT06954467
What this trial is testing

JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 72
Testing effectiveness (Phase 2)Study completedNCT00484211
What this trial is testing

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
AGC Biologics S.p.A. 40
Testing effectiveness (Phase 2)Study completedNCT00464919
What this trial is testing

Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06446154
What this trial is testing

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint InhibitorsAnti-angiogenic Therapy+1 more
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Study completedNCT00410956
What this trial is testing

Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center 22
Next Page